) News | Bausch + Lomb Surgical

News overview

Please note that the company does not make any updates, corrections or revisions after the publication of press releases. For the latest information about Bausch + Lomb, see the most recent publications.

News archive

Bausch + Lomb Acquires AcuFocus, Inc.

Acquisition Will Enhance Bausch + Lomb’s Surgical Portfolio with IC-8® Apthera™ Intraocular Lens

VAUGHAN, Ontario & IRVINE, Calif.--(BUSINESS WIRE)--Bausch + Lomb Corporation...

Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments s.r.l. Intraocular Dyes

Expansion Offering Enhances and Broadens Bausch + Lomb’s Surgical Portfolio with Unique and Clinically Proven Comprehensive Dye Platform

 

VAUGHAN, Ontario, and CASORIA, Naples,...

Bausch + Lomb announces its strategic partnership with Munich Surgical Imaging GmbH (MSI)

MONTPELLIER, FRANCE, 30 August 2022 – As announced by Joe Papa earlier this year, Bausch + Lomb, a leading global eye health business, is thrilled to announce today its strategic...

STELLARIS ELITE: “A platform with longevity: Why I consider the Bausch + Lomb Stellaris Elite platform a superior choice.” – Mr Mohammed Rifaat

The following article is a testimonial provided by Mr Mohammed Rifaat, Associate Specialist, Maidstone and Tunbridge Wells NHS Trust, UK, who gives us his opinion on the Stellaris...

STELLARIS ELITE: A track record not to be dismissed and machines which shine through the competition. – Prof. Nabil Habib

In the following testimonial Professor Nabil Habib, Consultant Ophthalmic Surgeon, University Hospitals Plymouth NHS Trust, explains why, in his opinion, Bausch + Lomb’s Stellaris...

POSITIVE OUTCOMES FOR PREMIUM LUXSMART™ INTRAOCULAR LENSES, FOLLOWING ONE-YEAR REAL-WORLD EXPERIENCE

Bausch + Lomb’s Premium Lens Designed for Providing Distance and Intermediate Continuous Vision with a Potentially Similar Dysphotopsia Profile as a Monofocal, Thanks to its Pure...

Contact